Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Steminent Biotherapeutics, Inc. (7729) Income Statement

Steminent Biotherapeutics, Inc. Income Statement

Last quarter (Q2 2026), Steminent Biotherapeutics, Inc.'s total revenue was NT$0.00. In Q2, Steminent Biotherapeutics, Inc.'s net income was NT$-111.03M. See Steminent Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 0.00NT$ 0.00NT$ 941.00KNT$ 636.00KNT$ 2.12M
NT$ -30.92MNT$ -16.43MNT$ -1.04MNT$ -8.93MNT$ -1.75M
NT$ 172.87MNT$ 145.87MNT$ 130.42MNT$ 79.88MNT$ 73.85M
Depreciation and AmortizationNT$ 30.92MNT$ 16.43MNT$ 12.06MNT$ 9.43MNT$ 11.33M
NT$ -142.74MNT$ -140.26MNT$ -115.39MNT$ -75.15MNT$ -111.54M
NT$ -172.87MNT$ -162.29MNT$ -131.46MNT$ -98.21MNT$ -75.59M
NT$ -1.27MNT$ 3.69MNT$ 2.23MNT$ 12.74MNT$ -48.61M
NT$ -174.15MNT$ -158.60MNT$ -129.23MNT$ -85.47MNT$ -124.20M
NT$ -174.04MNT$ -158.75MNT$ -129.23MNT$ -85.47MNT$ -124.20M
Per Share Metrics
Basic EPSNT$ -2.95NT$ -2.84NT$ -2.90NT$ -1.92NT$ -3.52
Diluted EPSNT$ -2.95NT$ -2.84NT$ -2.90NT$ -1.92NT$ -3.52
Weighted Average Shares Outstanding58.99M55.90M44.52M44.52M35.28M
Weighted Average Shares Outstanding (Diluted)58.99M55.90M44.52M44.52M35.28M

Currency in TWD

Steminent Biotherapeutics, Inc. Earnings and Revenue History

-200M-100M0100M-15000 %-10000 %-5000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin